Todd C. Brady

Executive

Chairman & CEO

Aldeyra Therapeutics, Inc.F-star Therapeutics, Inc.Evoke Pharma Inc

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 1 buy · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (2 ops.)

€417k

▼ Sales (1 ops.)

€293k

Latest filing published 05 Jun 2026 for Aldeyra Therapeutics, Inc., €360k. Read the official filing

Filing timeline

BuySale

Todd C. Brady

Insider track record

Disclosed buys

Disclosed sells

T+90 hit rate

T+90 mean return

-14.9%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Todd C. Brady: trading record in brief

Todd C. Brady is a declared insider at 3 companies (chief executive); the most frequent names are Aldeyra Therapeutics, Inc., Evoke Pharma Inc and F-star Therapeutics, Inc. The record holds 8 filings, for trades running from 30 March 2022 to 3 June 2026.

Market trades split into 2 purchases (€417k) and 1 sale (€293k). The net balance comes to €124k on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants and 1 option exercise. So far in 2026, the count stands at 1 purchase and no sales.

The newest entry dates from 5 June 2026: an open-market purchase of €360k, in Aldeyra Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.